Table 2.

AEs among all the treated patients

AEsAny gradeGrade 1Grade 2Grade 3Grade 4
Number of patients
CRS 
Fatigue 
ICANS 
Hypertension 
Sinus tachycardia 
Coagulation disorders 
Increased aspartate aminotransferase 
Increased alanine aminotransferase 
Cytopenia      
Neutropenia 13 
Anemia 12 
Thrombocytopenia 10 
Lymphopenia 13 
Hypogammaglobulinemia 12 12 
Infection      
Sepsis 
Shingles 
Upper respiratory infection 
Bacteria 
AEsAny gradeGrade 1Grade 2Grade 3Grade 4
Number of patients
CRS 
Fatigue 
ICANS 
Hypertension 
Sinus tachycardia 
Coagulation disorders 
Increased aspartate aminotransferase 
Increased alanine aminotransferase 
Cytopenia      
Neutropenia 13 
Anemia 12 
Thrombocytopenia 10 
Lymphopenia 13 
Hypogammaglobulinemia 12 12 
Infection      
Sepsis 
Shingles 
Upper respiratory infection 
Bacteria 

Listed are the grade 1 to 2 AEs that occurred in at least 15% of the patients, and all events of grade 3 or higher occurred in patients from the time of infusion of CAR T cells until day 90. The severities of the AEs were graded according to the CTCAE version 5.0 except CRS and ICANS, which were graded according to the criteria of Lee et al10 and a revised grading system, respectively.

or Create an Account

Close Modal
Close Modal